Heart Disease

It’s time for a frank conversation about women’s heart disease and who better to have it with than Atlantic Health System experts and nationally-recognized cardiologist C. Noel Bairey Merz. As the director of the Barbara Streisand Women’s Heart Center in Los Angeles, Dr. Merz has been consulted for her expertise by countless television shows and magazines. Her next appearance will be at Morristown Medical Center, where she’ll lecture on various aspects of women’s heart health, including the role of exercise, stress management, nutrition and more. Atlantic Health System cardiologists – Linda Gilliam, Claire Boccia Liang and Stephen Winters – will also join the conversation as part of a discussion panel. The event takes place on Friday, April 26, from 10:30am to Noon in our Malcolm Forbes Amphitheater. Register now >

Heart Disease Programs and Screenings

Education and prevention can keep you and your loved ones healthy. We invite you to take advantage of the programs, support groups and screenings available. Adults 65 and older who are looking to stay well with age may benefit from events labeled “New Vitality.”

Assess Your Stress Level
Find out if you’re over-stressed; no appointment necessary.
Wednesday, April 24; 3:00 to 5:00pm
Milford Health & Wellness, 111 East Catharine Street, Milford, PA
For information, please call 570-409-8484 ext. 501.
 
Heart Failure Support Group
Heart failure patients and/or their significant others can learn how to best manage their disease.
Second Thursday of every month; 1:00 to 2:00pm.
Newton Medical Center, Emergency Department Conference Room
For more information, please call 973-579-8364.
 
Quit Smoking Program
Learn techniques that can help you quit cigarettes and stay smoke free. Nicotine replacement products will be provided at no cost.
For upcoming dates and to register, please call 973-579-8373.

 
Heart Disease Articles
Read more
Read more
Read more
Read more

New Cholesterol Drug's High Price May Not Be Worth It: Study

WEDNESDAY, Jan. 2, 2019 -- Despite being slashed by half in recent months, the price tag for advanced cholesterol-fighting drugs is still too high to make them cost-effective, a new analysis has concluded.

In March, the manufacturer of alirocumab (Praluent) announced that it would cut the cost of the medication from $14,000 a year to $7,000.

Read more